Aug. 14, 2024 — More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive.
Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.
Low-density lipoprotein cholesterol (LDLC), also known as ‘bad cholesterol,’ contributes to plaque buildup in the arteries and causes damage, making it a ‘silent killer’ ...
JE: Human genetic studies provide strong target validation for the role of PCSK9 in modulating LDL cholesterol (LDL-C) levels and the risk of coronary heart disease (CHD).
Other studies show that psyllium can be paired with statins — a class of cholesterol-lowering medications — to support further reductions in cholesterol. Keep in mind that while fiber ...
High cholesterol fluctuations have been linked to a higher risk of developing dementia, including Alzheimer's and vascular dementia. Maintaining stable cholesterol levels through a healthy diet, ...